Parties Spar Over Federal Circuit’s ‘Full Scope’ Enablement Standard
WASHINGTON, D.C. — The U.S. Supreme Court heard oral arguments March 27 in a dispute between two pharmaceutical titans over antibodies that work to lower cholesterol and the proper enablement standard...To view the full article, register now.
Already a subscriber? Click here to view full article